Gain Therapeutics, Inc. (GANX) Financials

GANX Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 14.1 million 6.8 million
2023-06-30 18.3 million 7.2 million
2023-03-31 21.3 million 6.2 million
2022-12-31 24.1 million 5.2 million

GANX Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -4.0 million 907327
2023-06-30 -5.0 million 1.2 million
2023-03-31 -4.2 million 565432
2022-12-31 -3.9 million 558692

GANX Net Income

No data available :(

GANX Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 12.2 million - 494624
2023-06-30 16.2 million 466638 565869
2023-03-31 17.8 million 478296 618429
2022-12-31 20.1 million 495258 670864

GANX Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 12.7 million
2023-06-30 12.4 million
2023-03-31 11.9 million
2022-12-31 11.9 million

GANX Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 650 2.4 million 2.5 million -
2023-06-30 3644 4.0 million 3.7 million -
2023-03-31 11045 2.8 million 2.5 million -
2022-12-31 9398 2.3 million 2.3 million -

GANX Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 - 20509
2023-06-30 - 20239
2023-03-31 55180 19242
2022-12-31 140108 18110

GANX

Price: $2.91

52 week price:
2.00
5.61

Earnings Per Share: -1.71 USD

P/E Ratio: -2.65

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Volume: 17900

Market Capitalization: 48.0 million

Links: